Multiple chemical sensitivity/idiopathic environmental intolerance (MCS/IEI) is a commonly used diagnostic term for a group of symptoms without apparent organic basis. The symptoms are characteristic of dysfunction in multiple organ systems. They wax and wane fluctuate according to exposure to low levels of chemical agents in the patient's environment, and sometimes begin after a distinct environmental change or injury such an industrial accident or chemical introduced after remodeling. Although traditional medical organizations have not agreed on a definition for this syndrome, it is being increasingly recognized and makes up an increasing percentage of the caseload at occupational/environmental medical clinics.
Introduction
Multiple chemical sensitivity/idiopathic environmental intolerance (MCS/IEI) has been postulated to be a disease unique to modern industrial society in which certain people are suggested to acquire high sensitivity to numerous chemically unrelated environmental substances. The patient experiences wide-ranging symptoms, but evidence of pathology or physiologic dysfunction in such patients has been lacking in studies to date. Due to the subjective nature of the illness, an objective case definition is problematic. Allergic, immunotoxic, neurotoxic, cytotoxic, psychologic, sociologic, and iatrogenic theories have been postulated for both etiology and production of symptoms, but there is an absence of scientific evidence to establish any of these mechanisms as definitive. This article reviews the literature on diagnosis, clinical examinations, treatment, and long-term follow up of MCS/IEI, and demonstrates the relation of MCS/IEI with the diseases having similar symptoms, such as psychiatric diseases, sick-building syndrome, chronic fatigue syndrome (CFS), fibromyalgia (FM), allergic diseases, and Persian Gulf War (PGW) syndrome.
Diagnosis of MCS/IEI
There are some difficulties in making a widely accepted diagnosis of MCS/IEI because MCS/IEI patients report that so many inhaled and ingested chemical stimuli elicit symptoms, and also because elicited symptoms vary markedly among individuals (1-3). Diagnosis of multiple chemical sensitivity relies heavily on subjective symptoms and typically not on objective clinical or laboratory findings (4, 5). Since there is no widely accepted definition, the controversy and confusion regarding the etiology of MCS/IEI translate into poor medical diagnosis and treatment for patients. In an earlier study reported by Gibson et al. (6) , people with MCS/ IEI reported seeing a mean of 8.2 physicians each, waiting 7.5 years for a diagnosis, spending a considerable amount of money on their health, receiving misdiagnoses, and suffering iatrogenic harm.
As defined by Cullen (7), MCS/IEI is "…an acquired disorder characterized by recurrent symptoms, referable to multiple organ systems, occurring in response to demonstrable exposure to many chemically unrelated compounds at doses far below those established in the general population, and which cause harmful effects. No single widely accepted test of physiologic function can be shown to correlate with the symptoms (Table 1) ". Some investigators (8, 9) have elected to enroll patients in their studies based upon Cullen's criteria for MCS/IEI. However, this definition excludes 'definable' clinical conditions, such as asthma, which was suggested to overlap with MCS/IEI, and asthma may also be exposure-induced and is commonly reported by patients with MCS/IEI. Kreutzer et al. (10) also suggested an association between asthma and perceived chemical sensitivity.
As of 1993, five case definitions had been proposed (7, (11) (12) (13) (14) . The sixth definition, the 1999 consensus on multiple chemical sensitivity (Table 2) , was recently published (15). This definition has been widely used in many studies papers for selecting MCS/IEI patients since its publication. et al. (16) observed that good reproducibility regarding self-report of symptoms was shown in this case definition.
The role of physicians for MCS/IEI patients Spark et al. (17) warned that the usual approach for diagnosing MCS/IEI requires time and resource-intensive evaluation by a physician trained in occupational and environmental medicine. Problems regarding the diagnosis by physicians were reported by Kreutzer et al. (10) . Of the 253 people who reported doctordiagnosed MCS/IEI, 109 people (43.5 percent) did not also report unusual chemical sensitivity. In addition, they found, among traditional physicians, the lowest rate of 5% (95% CI=3, 9) in otolaryngology clinics, an intermediate rate of 13% (95% CI=9, 17) in the allergy practice, and the highest rate of 27% (95% CI=20, 35) among occupational medical clinics. The rates found in at investigation may also have been inflated because the participating study physicians had greater than average interest in MCS/IEI syndrome and, therefore, may have attracted a relatively larger proportion of such patients. Kreutzer et al. (10) also suggested that clinical ecologists are more likely than traditional physicians to ask questions about chemical sensitivities because such sensitivities are central to their interest.
The evaluating and the treating physician must be wary of excessive ordering in addition to misinterpretation of diagnostic tests because these may reinforce a detrimental pattern of illness behavior (18). As with other types of unexplained symptoms, the primary physician should function as a gatekeeper and should order diagnostic tests primarily to identify the presence of other environmental or non-environmental illnesses in the differential.
Clinical examinations
The difficulty in adequately defining the group of patients with MCS/IEI-like symptoms has been attributed to the use of varied nomenclature, the heterogeneity of substances and symptoms reported, the lack of objective findings upon physical examination, and the lack of consistent abnormal diagnostic testing, including provocation testing (8, 19, 20) . Thus, the diagnosis rests largely on self-reported symptoms.
Though most previous studies have tried to clarify the mechanisms, prevalence, or definition of MCS/IEI by conducting numerous kinds of questionnaires, several existing questionnaires focus only on one domain, such as the number of odorous chemical exposures that elicit symptoms or the frequency with which specific chemical odors cause illness (21, 22), and they do not attempt to include other facets of the illness. Other questionnaires propose idiosyncratic criteria (23). Others are long and are intended for hypothesis testing and, therefore, are not appropriate for screening (3). A recent formulation (10) proposes 15 questions, with a branching structure for the screening of "MCS/IEI sufferers in a medical setting," and it is defined in terms of 3 criteria: 〈1〉 physician-diagnosis of MCS/IEI, 〈2〉 self-assessed unusual sensitivity to chemicals, and 〈3〉 health problems which restrict the patient's daily activities. Hu et al. (24) also developed a parsimonious set of factors to screen for MCS/IEI that would allow greater applicability of such a screening instrument in population studies that have multiple objectives and that must employ a number of other questionnaires.
Other than questionnaires, some abnormal findings of MCS/ IEI patients have been reported. Abnormal MRI (25), nasal abnormalities (26), damaged detoxification pathways (27), and pesticides in blood (13) have been found in some studies.
With regard to electric encephalography, Bell et al. (28) found that middle-aged women with chemical intolerance and associated lifestyle changes sensitize resting frontal alpha activity in the EEG in comparison with depressed and normal controls from one session to the next. Furthermore, chemical exposure can elicit acute changes 4 Symptoms occur in response to low-level exposure to multiple agents of varying structural classes.
5
The doses of these agents are at least two ordors of magnitude lower than the established thresholds for acute health effects.
6
Tests of physiologic function are unable to explain the symptoms.
7
The pattern of symptoms cannot be explained by any other organic disorder. 
